Design of Aminopeptidase N Inhibitors as Anti-cancer Agents

J Med Chem. 2018 Aug 9;61(15):6468-6490. doi: 10.1021/acs.jmedchem.7b00782. Epub 2018 Apr 16.

Abstract

Aminopeptidase N (APN) is an important metalloenzyme. It regulates multivariate cellular functions by different mechanisms such as enzymatic cleavage of peptides. This may play a role in endocytosis and regulate signal transduction. APN, a member of the M1 zinc metallopeptidase family, plays crucial roles in a variety of functions such as migration and invasion, and angiogenesis and metastasis of tumor cells. Therefore, APN inhibitors may be useful for the treatment of cancer. In this Perspective, structure-activity relationships of APN inhibitors are discussed to get an idea of possible lead candidates. APN inhibitors should possess an aryl hydrophobic function along with a zinc binding group attached to the hydrophobic group(s) to achieve high potency. This and other design aspects of APN inhibitors are discussed in this Perspective.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • CD13 Antigens / antagonists & inhibitors*
  • CD13 Antigens / chemistry
  • CD13 Antigens / metabolism
  • Drug Design*
  • Humans
  • Molecular Targeted Therapy
  • Protease Inhibitors / chemistry
  • Protease Inhibitors / pharmacology*
  • Protease Inhibitors / therapeutic use

Substances

  • Antineoplastic Agents
  • Protease Inhibitors
  • CD13 Antigens